FDA requirements for private label cosmetics in the United States apply to more than the factory that makes the product. A private label brand may become the “responsible person” when its name appears on the label, while the manufacturer or processor may have separate facility obligations. Before launching lipstick, lip gloss, eyeliner, foundation, skincare, or another cosmetic, both parties should document who will handle registration, product listing, safety records, labeling, adverse-event reporting, and updates.
This guide summarizes the main federal requirements that U.S. private label brands should review under the Federal Food, Drug, and Cosmetic Act, the Fair Packaging and Labeling Act, and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). It is general business information, not legal advice. Requirements can depend on the product, claims, facility, company size, and supply chain, so confirm the current FDA rules and obtain qualified regulatory advice for your specific launch.
1. FDA Registration Is Not FDA Approval
Most cosmetic products and cosmetic ingredients do not require FDA premarket approval. The major exception is color additives, which must be approved for their intended use; some also require FDA batch certification. A cosmetic facility registration or cosmetic product listing is not an approval, endorsement, or marketing certificate.
FDA specifically states that cosmetic facility registration and product listing are neither a cosmetic approval program nor a promotional tool. Brands should therefore avoid statements such as “FDA approved cosmetics” unless the statement is legally accurate for a particular regulated item. A supplier describing itself as an “FDA registered cosmetics manufacturer” should be asked for current facility registration information, but registration alone does not prove that every formula, label, claim, or product complies with U.S. law.
2. Confirm Whether the Product Is a Cosmetic, Drug, or Both
Classification depends largely on intended use, which may be shown by product claims, labeling, advertising, consumer perception, and ingredients. A product intended only to cleanse, beautify, promote attractiveness, or alter appearance may be a cosmetic. A product promoted to treat or prevent disease or affect the structure or function of the body may also be a drug.
For example, color cosmetics such as lipstick, eyeshadow, blush, and conventional foundation are generally sold as cosmetics. Claims to treat acne, grow eyelashes, heal eczema, or change a biological function may create drug implications. Sunscreen products are regulated as drugs in the United States. Do not approve claims based only on marketing trends; review the exact product wording before printing packaging or publishing a product page.
3. Identify the Responsible Person
MoCRA defines the responsible person as the manufacturer, packer, or distributor whose name appears on the cosmetic product label. In many private label projects, the brand or distributor named on the label may be the responsible person even when a third-party cosmetic OEM manufacturer produces the goods.
The manufacturing agreement should clearly state who is the responsible person and who will perform each regulatory task. Outsourcing the formula and filling does not automatically transfer all legal duties to the factory. The brand should retain access to the information and records needed to support its own obligations.
4. Cosmetic Facility Registration
Manufacturers and processors that are subject to MoCRA must register each applicable cosmetic facility with FDA and renew the registration every two years. The owner or operator is responsible for the facility submission. FDA uses the FDA Establishment Identifier, or FEI, as the required facility registration number.
A private label brand should confirm the legal name and address of the actual manufacturing or processing facility, not only the trading company or sales office. Ask who owns the registration, whether it is active, when renewal is due, and which facility performs each relevant operation. Foreign facilities should follow the current FDA submission instructions, including any applicable U.S. agent information.
Registration must not be presented as a substitute for formula review, testing, quality systems, or compliant labeling. FDA also has authority to suspend a facility registration under specified serious safety circumstances.
Ya-Orange compliance note: Ya-Orange has an FDA Establishment Identifier (FEI) and has completed the applicable cosmetic facility registration process. The FEI identifies the establishment and does not mean that FDA has approved individual cosmetic products. Ya-Orange can assist customers with cosmetic product listing data preparation and submission-process coordination. The responsible person remains responsible for ensuring that listing information is complete and accurate, maintaining required records, and providing annual updates when required. Facility registration must be maintained and renewed as required, while each marketed product must separately meet applicable labeling, safety, and recordkeeping requirements.
5. Cosmetic Product Listing
The responsible person must list each marketed cosmetic product with FDA unless an exemption applies. The listing includes information such as the facility registration number, responsible-person details, product category, product name, and ingredients. FDA states that required product-listing updates must be provided annually.
Private label brands should decide who will prepare and submit listings, who will maintain the data, and how formula or label changes will be communicated. If one formula is sold in multiple shades, packages, or brand versions, the parties should follow FDA’s current listing guidance for how those products may be grouped or submitted. Keep the listing data aligned with the approved formula and the product actually sold.
6. Safety Substantiation and Records
A responsible person must ensure and maintain records supporting adequate safety substantiation for the cosmetic product. FDA does not prescribe one universal test package for every cosmetic. Relevant support may include ingredient safety information, toxicological data, formula assessments, stability or compatibility data, microbiological controls, and other scientifically robust evidence appropriate to the product and intended use.
Ask the private label cosmetics manufacturer what safety and quality documentation will be available for the finished formula. A certificate of analysis, material specification, safety data sheet, or stability result serves a particular purpose; no single document automatically proves full product compliance. The brand should understand which records support the final formula, packaging, shelf life, directions, and claims.
7. Serious Adverse Event Reporting
The responsible person must report a serious adverse event associated with use of a cosmetic product in the United States to FDA within 15 business days. The submission must include a copy of the label on or within the retail packaging. If relevant new medical or other information is received within one year after the initial report, the responsible person must submit that information within 15 business days.
Each cosmetic product must also bear a domestic address, domestic phone number, or electronic contact information through which the responsible person can receive adverse-event reports. A website may qualify as electronic contact information when it enables consumers to make reports. Brands need a written process to receive, evaluate, retain, escalate, and report complaints rather than relying on informal customer-service messages.
8. U.S. Cosmetic Labeling Requirements
Cosmetics marketed in the United States, including imported private label products, must comply with FDA labeling requirements and other applicable federal rules. Required information depends on the package and product, but commonly includes:
- a statement of identity describing what the product is
- an accurate net quantity of contents on the principal display panel
- the name and place of business of the manufacturer, packer, or distributor
- wording such as “Manufactured for” or “Distributed by” when the named business is not the manufacturer
- an ingredient declaration using appropriate names and order
- required warnings or directions for safe use when applicable
- the adverse-event contact information required by MoCRA
- English-language statements required under FDA regulations
Label space should be planned before packaging artwork is finalized. Obtain the component printable area and carton dieline, then verify the label on the actual package size. A visually attractive design can still be misbranded if required information is missing, misleading, too difficult to read, or placed incorrectly.
9. Ingredient and Color Additive Compliance
Retail cosmetics generally need an ingredient declaration using common or usual ingredient names in the required order. For color cosmetics, color-additive compliance deserves special attention. A color additive must be permitted for the intended use, meet applicable specifications and restrictions, and be batch certified when required.
Permission is use-specific. A color allowed for external use is not automatically allowed in the eye area, and a color permitted in one cosmetic category may have different restrictions in another. Ask the manufacturer to verify every color additive against the intended product and application area, especially for eyeliner, eyeshadow, lip products, and multiuse formulas.
10. Claims Must Be Truthful and Supported
FDA does not pre-approve ordinary cosmetic claims, but claims must be truthful and not misleading. Drug claims can change the product’s regulatory category. Other statements such as “hypoallergenic,” “non-comedogenic,” “dermatologist tested,” “cruelty-free,” “vegan,” “organic,” wear-time, waterproof, or free-from claims should not be added automatically. Confirm the meaning, formulation, test support, supplier documentation, and any other agency requirements that apply before publication.
Keep website copy, retailer listings, social-media advertising, packaging, and sales materials consistent. A compliant carton cannot correct an unlawful claim made online.
11. Imported Private Label Cosmetics Follow the Same U.S. Rules
Imported cosmetics must comply with the same U.S. laws and regulations that apply to domestically produced products. FDA may examine shipments, review labels, and collect samples. Color additive violations, misleading claims, contamination, and incomplete entry information can create import delays or detention risks.
Before shipment, align the manufacturer name and address, responsible-person information, facility data, product listing, ingredient list, color additives, label copy, country-of-origin marking, importer information, and customs documents. FDA and U.S. Customs and Border Protection have different roles, so an importer should review both FDA entry requirements and customs obligations.
12. Small-Business Exemptions Are Limited
MoCRA provides certain small-business exemptions from facility registration, product listing, and future GMP requirements. However, exemptions do not apply to several specified product types, including products that regularly contact the eye’s mucous membrane, injected products, products intended for internal use, and certain products intended to alter appearance for more than 24 hours when consumer removal is not part of customary use.
Do not assume that low sales, a startup status, or a low minimum order quantity automatically creates an exemption. Review the statutory definition, product type, average sales calculation, affiliates, and current FDA guidance with qualified counsel.
13. Track Developing MoCRA Rules
MoCRA directs FDA to establish regulations for cosmetic good manufacturing practices, fragrance allergen labeling, and standardized asbestos testing methods for talc-containing cosmetic products. As of this article’s publication, FDA’s MoCRA page continues to direct industry to developing rulemaking and guidance resources for these areas. Brands should monitor official FDA updates rather than relying on an old compliance checklist.
Private Label Cosmetics FDA Compliance Checklist
- confirm whether the product is a cosmetic, drug, or both
- identify the responsible person named on the label
- verify the actual manufacturing facility and applicable registration status
- assign responsibility for product listing and annual updates
- maintain adequate safety-substantiation records
- build a serious-adverse-event intake and reporting process
- review ingredient names, color additives, warnings, and package layout
- verify every marketing claim before printing or publishing
- align FDA information, import documentation, and the finished product
- monitor current MoCRA rules, guidance, renewal dates, and exemptions
Work With a Manufacturer That Supports Clear Documentation
FDA requirements for private label cosmetics should be addressed before mass production, not after products reach a U.S. port or retailer. When requesting a quotation, provide the intended market, product type, claims, shades, packaging, sales channel, and responsible-person plan. Ask which documents the manufacturer supplies and which regulatory tasks remain with the brand.
Review our cosmetic OEM/ODM process, browse private label cosmetic products, and contact Ya-Orange to discuss formula, packaging, documentation, and sampling requirements for your U.S. project.
Official FDA resources: MoCRA overview, facility registration and product listing, cosmetic labeling requirements, and color additive requirements.